Welcome to our dedicated page for Novanta SEC filings (Ticker: NOVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Novanta Inc. (Nasdaq: NOVT) files a range of documents with the U.S. Securities and Exchange Commission that shed light on its operations as a global supplier of core technology solutions for medical, life science, and advanced industrial OEMs. This SEC filings page brings together those disclosures so investors can review the company’s regulatory record in one place.
Among the most frequently referenced filings are current reports on Form 8-K, where Novanta announces quarterly financial results, provides non-GAAP metrics such as Adjusted EBITDA and Adjusted Diluted EPS, and discloses material events. Recent 8-K filings have covered results for specific fiscal quarters, revisions to financial guidance, changes in Board composition, and details of share repurchase authorizations.
Filings also document capital markets and financing transactions, including the underwriting agreement and terms of Novanta’s tangible equity units offering, which combines prepaid stock purchase contracts with senior amortizing notes due 2028. Related 8-Ks describe settlement mechanics, interest and installment payments, and the listing of the units under the symbol NOVTU. Other filings outline the terms of the company’s senior credit facilities under its Fourth Amended and Restated Credit Agreement and subsequent amendments, including leverage and coverage covenants.
Through this page, users can access Novanta’s 10-K annual reports and 10-Q quarterly reports (when filed), as well as Forms 4 and other ownership-related filings, via real-time updates from EDGAR. AI-powered summaries help explain complex sections, highlight key changes from prior periods, and clarify the implications of items such as guidance revisions, credit agreement provisions, and share repurchase programs.
Whether reviewing earnings-related disclosures, tracking capital structure developments, or examining governance and compensation information, this filings hub provides a structured entry point into Novanta’s SEC reporting history.
Novanta Inc. is calling a virtual 2026 annual shareholder meeting on May 28 to elect nine directors, hold an advisory vote on executive pay, and ratify Deloitte & Touche LLP as auditor until the 2027 meeting. Shareholders of record on April 14, 2026 can vote online, by phone, or by mail.
The board has nine members, eight of whom are independent, with a combined Chair/CEO and a separate independent Lead Director. Directors receive cash retainers and annual restricted stock units, and an annual “say‑on‑pay” vote will continue. Deloitte, auditor since 2024, received total fees of $2.32 million in 2025, mainly for audit work.
Novanta Inc. Chief Executive Officer Matthijs Glastra reported an open-market sale of 6,500 shares of common stock. The shares were sold at a weighted-average price of $130.05 per share on April 17, 2026, under a pre-established Rule 10b5-1 trading plan.
Following this sale, he directly owns 56,761 shares of Novanta common stock and has an additional 54,382 shares held indirectly through the Matthijs Glastra 2021 Irrevocable Trust. The transaction was executed in multiple trades between $130.00 and $130.28 per share.
Novanta, Inc. filing under Rule 144 discloses recent restricted stock unit grants and several secondary sales by a reporting holder. The excerpt lists RSU grants dated 02/24/2025 (1,900 shares), 02/28/2020 (2,076 shares) and earlier grants, and four sales by Matthijs Glastra on 01/21/2026, 02/02/2026, 02/10/2026, and 03/02/2026 for 7,500; 6,500; 7,500; and 6,500 shares respectively, with corresponding gross amounts shown.
Novanta Inc: The Vanguard Group filed an amended Schedule 13G/A reporting zero shares beneficially owned and 0% of Novanta Inc common stock following an internal realignment. The filing explains certain Vanguard subsidiaries will report disaggregated holdings after the January 12, 2026 realignment. The form is signed by Ashley Grim on 03/27/2026.
NOVANTA INC Chief Financial Officer Robert Buckley exercised stock options covering 9,957 shares of common stock at $14.13 per share and, on the same day, sold 9,957 shares in multiple open-market transactions at prices between $116.02 and $118.80. The filing notes these sales were effected under a pre-established Rule 10b5-1 trading plan adopted on March 13, 2025. After these transactions, Buckley holds 96,616 shares directly and 36,219 shares indirectly through the Buckley Family Irrevocable Trust.
Novanta Inc. Chief Executive Officer Matthijs Glastra reported open-market sales of 6,500 shares of common stock on March 2, 2026. The shares were sold in multiple transactions at prices ranging from $131.92 to $140.48 per share under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025. Following these sales, he holds 63,261 shares directly and 54,382 shares indirectly through the Matthijs Glastra 2021 Irrevocable Trust.
Novanta, Inc. reported insider resale activity: Form 144 filings show Matthijs Glastra sold common stock on multiple dates. The excerpt lists sales of 323 shares for $41,990 on 01/08/2026, 6,177 shares for $803,010 on 01/09/2026, 7,500 shares for $1,050,000 on 01/21/2026, 6,500 shares for $877,500 on 02/02/2026, and 7,500 shares for $1,087,500 on 02/10/2026.
The filing also lists a broker/placement detail referencing Merrill Private Wealth Management and an apparent filing date of 03/02/2026. These entries are routine Form 144 resale notices reporting amounts and dates of reported dispositions.
Novanta Inc. Co-Chief Operating Officer Charles Guy Ravetto, Jr. reported transactions related to restricted stock units and common shares. On February 24, he exercised 825 restricted stock units into 825 common shares at no cost, then disposed of 243 common shares at $137.44 per share to cover tax obligations. Following these transactions, he held 16,116 common shares directly.
Novanta Inc. chief accounting officer John Joseph Burke II reported routine equity award activity. He exercised 479 Restricted Stock Units, each converting into one common share, and received 479 common shares at a stated price of $0.0000 per share. Following this derivative exercise, his direct common stock holdings increased to 9,041 shares, before a separate tax-related transaction.
On the same date, Burke disposed of 141 common shares at $137.44 per share in a transaction coded "F," which represents shares withheld or delivered to cover tax liabilities associated with the award. After this tax-withholding disposition, his directly owned common shares totaled 8,900.